Mark Humphrey

1.8k citations
10 papers · 1.5k · h-index 9

Impact in

  • Oncology top 5%
    • Peptidase Inhibition and Analysis
    • Cancer Cells and Metastasis
    • Protease and Inhibitor Mechanisms
    • Cancer Genomics and Diagnostics

Papers in

    • Peptidase Inhibition and Analysis 2
    • Cancer Immunotherapy and Biomarkers 2
    • Cancer Cells and Metastasis 2
    • Ubiquitin and proteasome pathways 1

Mark Humphrey

10 papers receiving 1.5k citations

Peers

Mark Humphrey
Comparison fields: 5 of 96
  • Oncology 613
  • Cancer Research 323
  • Spectroscopy 240
  • Molecular Biology 831
  • Organic Chemistry 342
Replace Lacey E. Dobrolecki with:
Lacey E. Dobrolecki United States
Raymond E. Moellering United States
Katherine R. Kozak United States
Kareem A. H. Chehade United States
Jeong Heon Ko South Korea
Darrin D. Stuart United States
Feifei Xu China
Jack H. Lai United States
Jeffrey H. Till United States
Matilde Olivé United States
Mark Humphrey relative to Lacey E. Dobrolecki United States Lacey E. Dobrolecki's profile →
Citations per field
00.5×1.5×1.8×
Lacey E. Dobrolecki · 1×
Citations per year

Countries citing papers authored by Mark Humphrey

Since Specialization
Citations

This map shows the geographic impact of Mark Humphrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Humphrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Humphrey more than expected).

Fields of papers citing papers by Mark Humphrey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Humphrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Humphrey. The network helps show where Mark Humphrey may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Humphrey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Humphrey Line = papers co-authored together Mark Humphrey links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 2004381
2 2002303
3 2005207
4 2004162
5 2014157
6 2006144
7 2006132
8 198122
9 198321
10 20151

About Mark Humphrey

Mark Humphrey is a scholar working on Oncology, Molecular Biology, Spectroscopy, Cancer Research and Cell Biology, having authored 10 papers that have together received 1.5k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (3 papers), Immunotherapy and Immune Responses (2 papers), Peptidase Inhibition and Analysis (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Protease and Inhibitor Mechanisms (2 papers), Cancer Cells and Metastasis (2 papers), Click Chemistry and Applications (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Oncology (613 citations), Cancer Research (323 citations), Spectroscopy (240 citations), Molecular Biology (831 citations) and Organic Chemistry (342 citations). Mark Humphrey has collaborated with scholars based in United States and South Korea. Frequent co-authors include Nadim Jessani, Benjamin F. Cravatt, Alan Saghatelian, Yongsheng Liu, John R. Yates, Sherry Niessen, Kelly Bethel, Richard H. Bruce, Jorgé Nieva and Robert T. Krivacic. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Surgical Oncology, Journal of Hepatology, Annals of Surgery and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact